Ian M. Estepan is the President and Chief Operating Officer of Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a biopharmaceutical company focused on precision genetic medicines for rare diseases.( Appointed to this role in July 2025, he oversees Finance, Commercial, Business Development, Government and Patient Affairs, and Corporate Affairs; he previously served as Executive Vice President and Chief Financial Officer from December 2020.( Estepan joined Sarepta in January 2015 as Senior Director of Corporate Affairs, advancing through roles including Executive Director, Vice President and Chief of Staff, and Senior Vice President, during which he helped secure $2.5 billion in capital, established corporate strategy and program management functions, and led investor relations.(

Prior to Sarepta, Estepan managed a multi-million-dollar buy-side portfolio of biotechnology, medtech, and pharmaceutical equities at Spectra Financial Group for 15 years, following early roles as a healthcare analyst at Salomon Smith Barney and at The Music Booth, LLP.( He holds a Bachelor of Arts in Psychology with a pre-medicine concentration from Columbia University, graduating magna cum laude.( Estepan serves on Cellarity's Board of Directors since 2021 and as Executive Chairman of AbBC Therapies, Inc.; in 2022, he was named a Boston Business Journal CFO of the Year.( As a corporate insider, he owns approximately 193,300 shares of SRPT valued at around $4 million as of December 2025 and recently sold 13,187 shares on December 16, 2025.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.